SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
| Revenue (Most Recent Fiscal Year) | $65.17M |
| Net Income (Most Recent Fiscal Year) | $-62.49M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.85 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.24 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -96.41% |
| Net Margin (Trailing 12 Months) | -98.51% |
| Return on Equity (Trailing 12 Months) | -63.47% |
| Return on Assets (Trailing 12 Months) | -40.06% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.11 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.94 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.16 |
| Inventory Turnover (Trailing 12 Months) | 3.58 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.28 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.26 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.95 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.00 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 66.69M |
| Free Float | 63.43M |
| Market Capitalization | $191.39M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 1.03 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.88% |
| Percentage Held By Institutions (Latest 13F Reports) | 31.59% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |